November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
Sep 16, 2025, 02:44

Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)

Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:

“First reported inhibitor development in haemophilia A gene therapy Presented by Davide Matino at BIC meeting at Phase 3 giroctocogene fitelparvovec (AAV6, 3×10¹³ vg/kg, n=74).

Patient Profile:

  • Genetic: Intron 22 inversion
  • History: ITP + splenectomy
  • Comorbidities: HCV & HIV co-infection
  • Experience: 6,000 exposure days with FVIII

Clinical Timeline:

  • Peak FVIII (day 75 after gene therapy): 441.7%
  • Post-infusion: Multiple steroid courses for ↑ALT/AST
  • Inhibitor development more than 1 year after treatment”

Wolfgang Miesbach

More recent insights on Hemostasis Today.